pubmed.ncbi.nlm.nih.gov

Cannabis and psychiatric disorders: it is not only addiction - PubMed

Review

Cannabis and psychiatric disorders: it is not only addiction

F Markus Leweke et al. Addict Biol. 2008 Jun.

Abstract

Since the discovery of the endocannabinoid system, a growing body of psychiatric research has emerged focusing on the role of this system in major psychiatric disorders like schizophrenia (SCZ), bipolar disorder (BD), major depression and anxiety disorder. Continuing in the line of earlier epidemiological studies, recent replication studies indicate that frequent cannabis use doubles the risk for psychotic symptoms and SCZ. Further points of clinical research interest are alterations of endocannabinoids and their relation to symptoms as well as postmortem analyses of cannabinoid CB(1) receptor densities in SCZ. A possible neurobiological mechanism for the deleterious influence of cannabis use in SCZ has been suggested, involving the disruption of endogenous cannabinoid signaling and functioning. Even though the number of studies is still limited for affective and anxiety disorders, previous results suggest these diseases to be exciting objectives of cannabinoid-associated research. Therefore, it became apparent that cannabis use is not only frequent in patients suffering from BD, but that it also induces manic symptoms in this group. In addition, prior antipsychotic treatment decreased the numerical density of CB(1) immunoreactive glial cells in bipolar patients. Although the data on the influence of cannabis use on the development of major depression is controversial, cannabinoid compounds could display a new class of medication, as suggested by the antidepressive effects of the fatty acid amino hydrolase inhibitor URB597 in animal models. With numerous open questions and controversial results, further research is required to specify and extend the findings in this area, which provides a promising target for novel pharmacotherapeutic interventions.

PubMed Disclaimer

Cited by

Cannabis involvement in individuals with bipolar disorder.
Agrawal A, Nurnberger JI Jr, Lynskey MT; Bipolar Genome Study. Agrawal A, et al. Psychiatry Res. 2011 Feb 28;185(3):459-61. doi: 10.1016/j.psychres.2010.07.007. Epub 2010 Jul 31. Psychiatry Res. 2011. PMID: 20674039 Free PMC article.
Cannabinoid modulation of limbic forebrain noradrenergic circuitry.
Carvalho AF, Mackie K, Van Bockstaele EJ. Carvalho AF, et al. Eur J Neurosci. 2010 Jan;31(2):286-301. doi: 10.1111/j.1460-9568.2009.07054.x. Epub 2010 Jan 13. Eur J Neurosci. 2010. PMID: 20074224 Free PMC article.
[Managing the use of cannabis in a young population in primary care].
Madoz-Gúrpide A, Ochoa Mangado E. Madoz-Gúrpide A, et al. Aten Primaria. 2011 Jun;43(6):319-24. doi: 10.1016/j.aprim.2010.10.002. Epub 2011 Feb 20. Aten Primaria. 2011. PMID: 21342718 Free PMC article. Spanish.
Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion.
López-Gallardo M, López-Rodríguez AB, Llorente-Berzal Á, Rotllant D, Mackie K, Armario A, Nadal R, Viveros MP. López-Gallardo M, et al. Neuroscience. 2012 Mar 1;204:90-103. doi: 10.1016/j.neuroscience.2011.09.063. Epub 2011 Oct 6. Neuroscience. 2012. PMID: 22001306 Free PMC article.
Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.
van Enkhuizen J, Geyer MA, Minassian A, Perry W, Henry BL, Young JW. van Enkhuizen J, et al. Neurosci Biobehav Rev. 2015 Nov;58:4-18. doi: 10.1016/j.neubiorev.2015.08.008. Epub 2015 Aug 19. Neurosci Biobehav Rev. 2015. PMID: 26297513 Free PMC article. Review.

Cannabis and psychiatric disorders: it is not only addiction - PubMed